<DOC>
	<DOCNO>NCT01282034</DOCNO>
	<brief_summary>INTRODUCTION Marrow stimulation technique subchondral drilling microfractures represent one frequently use method chondral osteochodral defect repair consider standard technique . MaioRegen® ( Fin-Ceramica Faenza S.p.A. , Italy ) bioceramic , multi-layered scaffold , single gradient structure , consist deantigenated Type I equine collagen Magnesium enriched-Hydroxyapatite , able mime entire osteocartilaginous section . MaioRegen® able promote tissue regeneration case severe large chondral/osteochondral lesion , otherwise difficult treat , previously demonstrate vitro , vivo clinical study . OBJECTIVES The present study proposes compare MaioRegen® performance respect reference standard surgical technique ( microfractures subchondral drill ) treatment chondral/osteochondral lesion , order consolidate MaioRegen® , innovative surgical approach . STUDY DESIGN The clinical trial multicenter , prospective , randomize , control , two-arm , single-blind involves eleven European centre 150 patient . Eligible subject randomly allocate one two treatment group : control group , treat marrow stimulation technique , treatment group , treat MaioRegen® implant . Patient defect evaluate pre-operatively patient enrol must meet entry criterion trial . Before enrolment , subject declare voluntary participation study inform consent signature . Arthroscopic control carry immediately randomization thus surgical treatment , confirm characteristic lesion treat finalizing recruitment . For patient 6 , 12 24 month post-operative follow-up visit carry follow-up visit Case Report Form ( CRF ) fill specific section . Within CRF , follow-up section , commonly use specific score assign establish end-points ( IKDC , KOOS , Tegner Score , VAS , MRI Mocart Scoring System ) . Patients select randomized undergo one two study group , prescribe randomization list .</brief_summary>
	<brief_title>Study Treatment Knee Chondral Osteochondral Lesions</brief_title>
	<detailed_description>Post-operative MRI exam carry patient follow-up visit , 6 , 12 24 month post-op. , centrally blind evaluated two senior radiologist . STATISTICS The study design demonstrate superiority MaioRegen® compare marrow stimulation technique . On basis previous evidence , assume minimum difference modification IKDC Subjective Knee Evaluation Score MaioRegen® control therapy , sample size estimate 74 patient group ( power=90 % , first type error α=5 % , drop-outs=10 % ) , total sample size 148 subject . The analysis primary end-point evaluation change baseline two year , IKDC Subjective Knee Evaluation Score , compare result two group . Secondary end-points ( functional improvement , quality life improvement , tissue regeneration ) undergo analyse primary end-point , follow-up visit . Frequency table provide overall judgement treatment . The incidence gravity frequency eventual event surgery tabulate . The study conduct approval ethic committee board centre possibly national competent authority .</detailed_description>
	<criteria>1 . Patients provide write informed consent ; 2 . Patients age 18 60 year ; 3 . Knee symptomatic chondral lesion grade III/IV ( accord Outerbridge Classification ) osteochondral lesion ; 4 . Not refixable OCD lesion ; 5 . Lesion 29 cm2 ; 6 . Single lesion ; 7 . Patients agree actively participate rehabilitation protocol followup program ; 8 . Male female patient ; 9 . Women childbearing age use proven method prevent pregnancy , surgical treatment . 1 . Patients incapable understanding ; 2 . Patients participate previous , concurrent , trial ( ongoing complete within 3 month ) ; 3 . Patients surgically treat defect within one year ; 4 . Known allergy collagen calciumphosphates ; 5 . Patients affected malignancy ; 6 . Patients affect metabolic thyroid disorder ; 7 . Patients used alcohol drug ( medication ) abuse ; 8 . Patients affect advanced osteoarthritis ( KellgrenLawrence grade ≥3 ) ; 9 . Patients affect synovitis ; 10 . Untreated patellofemoral malalignment ; 11 . Varus valgus malalignment exceed 5° ; 12 . Body Mass Index &gt; 30 ; 13 . Patients previously treat total partial meniscectomy ( &gt; 50 % meniscus dimension ) ; 14 . Multiple lesion ; 15 . Kissing lesion ; 16 . Chondral/osteochondral tibial plate defect ; 17 . Concomitant menisci chondral/osteochondral defect treat ; 18 . Untreated knee ligament instability .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>CHONDRAL</keyword>
	<keyword>OSTEOCHONDRAL</keyword>
</DOC>